Library›Scenarios›Psychedelics in clinical context

Scenarios

Practical

Psychedelics in clinical context

Clinical research with psilocybin, MDMA, and related compounds is demonstrating measurable efficacy for treatment-resistant depression, PTSD, and end-of-life anxiety — conditions that have resisted conventional intervention. These substances appear to work partly by temporarily disrupting the default mode network, dissolving the rigid self-structures that maintain suffering, and creating a window for new perspective and integration. The tradition has always recognized that altered states can catalyze insight; what is new is the capacity to study the mechanisms with precision.

Patan

Online

The coach is replying…

40 scenarios

How siblings navigate different responses to psychedelic grief therapy How to access psychedelic therapy without financial resources How to approach psychedelic therapy with chronic pain How to approach psychedelic therapy with control trauma How to approach psychedelic therapy with core shame wounds How to continue psychedelic therapy after losing your therapist How to discuss therapeutic psychedelic use with children How to find support after therapist rejection of psychedelic use How to ground after extended depersonalization from ayahuasca How to honor spiritual calling without cultural appropriation How to manage addiction fears in ketamine therapy How to manage heightened empathy after psychedelic therapy How to navigate career disillusionment after psychedelic insights How to navigate group projects when everyone's life is falling apart How to navigate sexual awakening after trauma therapy How to rebuild trust after hiding substance use from therapist How to trust psychedelic insights about major life changes When couples can't talk about money due to past trauma When couples do MDMA therapy separately but live together When death visions in ketamine therapy become overwhelming When ego dissolution leads to emotional numbness When emotional flooding continues after MDMA therapy When family members are in therapy but not connecting at home When family members want the same psychedelic treatment When family opposes psychedelic treatment for inner knowing When MDMA therapy benefits fade and trauma symptoms return When mental health professionals need psychedelic therapy When psychedelic aftereffects blur spiritual and psychiatric concerns When psychedelic integration groups become emotionally complicated When psychedelic therapy creates relationship jealousy When romantic relationships develop in psychedelic therapy groups When to taper antidepressants before psychedelic therapy When traumatic memories repeat without resolution in therapy When your partner becomes your psychedelic guide and it goes wrong When your psychedelic couples therapist shows signs of instability Whether microdosing conflicts with contemplative practice Whether microdosing replaces or supports deeper healing work Why MDMA therapy sometimes triggers anger instead of empathy Why mystical experiences can worsen depression afterward Why some people don't respond to ketamine therapy